Sientra stock climbs despite reporting higher net losses

You are here: Home > Biotech > Current Article

Sientra stock climbs despite reporting higher net losses

By Staff Report / Thursday, August 8th, 2019 / Comments Off on Sientra stock climbs despite reporting higher net losses

Goleta-based breast implant maker Sientra topped $20 million in sales for its second quarter, the company announced Aug. 8, sending shares up more than 13 percent after the market closed. Net losses ballooned 126 percent to $40.8 million, or $1.19 per share, nearly double average analyst estimates of 67 cents per share. The increase came…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.